IRIS Accounts Production v25.4.0.155 04273097 Board of Directors 1.7.24 30.6.25 30.6.25 9.12.25 false true false false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042730972024-06-30042730972025-06-30042730972024-07-012025-06-30042730972023-06-30042730972023-07-012024-06-30042730972024-06-3004273097ns15:EnglandWales2024-07-012025-06-3004273097ns14:PoundSterling2024-07-012025-06-3004273097ns10:Director12024-07-012025-06-3004273097ns10:PrivateLimitedCompanyLtd2024-07-012025-06-3004273097ns10:SmallEntities2024-07-012025-06-3004273097ns10:Audited2024-07-012025-06-3004273097ns10:SmallCompaniesRegimeForDirectorsReport2024-07-012025-06-3004273097ns10:SmallCompaniesRegimeForAccounts2024-07-012025-06-3004273097ns10:FullAccounts2024-07-012025-06-300427309712024-07-012025-06-3004273097ns10:OrdinaryShareClass12024-07-012025-06-3004273097ns10:Director32024-07-012025-06-3004273097ns10:Director42024-07-012025-06-3004273097ns10:CompanySecretary12024-07-012025-06-3004273097ns10:RegisteredOffice2024-07-012025-06-3004273097ns5:CurrentFinancialInstruments2025-06-3004273097ns5:CurrentFinancialInstruments2024-06-3004273097ns5:ShareCapital2025-06-3004273097ns5:ShareCapital2024-06-3004273097ns5:RetainedEarningsAccumulatedLosses2025-06-3004273097ns5:RetainedEarningsAccumulatedLosses2024-06-3004273097ns5:IntangibleAssetsOtherThanGoodwill2024-07-012025-06-3004273097ns5:ComputerSoftware2024-07-012025-06-3004273097ns5:LongLeaseholdAssetsns5:LandBuildings2024-07-012025-06-3004273097ns5:ComputerEquipment2024-07-012025-06-3004273097ns5:ComputerSoftware2024-06-3004273097ns5:ComputerSoftware2025-06-3004273097ns5:ComputerSoftware2024-06-3004273097ns5:LongLeaseholdAssetsns5:LandBuildings2024-06-3004273097ns5:ComputerEquipment2024-06-3004273097ns5:LongLeaseholdAssetsns5:LandBuildings2025-06-3004273097ns5:ComputerEquipment2025-06-3004273097ns5:LongLeaseholdAssetsns5:LandBuildings2024-06-3004273097ns5:ComputerEquipment2024-06-3004273097ns5:WithinOneYearns5:CurrentFinancialInstruments2025-06-3004273097ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3004273097ns10:OrdinaryShareClass12025-06-30
REGISTERED NUMBER: 04273097 (England and Wales)


























FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025

FOR

GENOVA DIAGNOSTICS EUROPE LTD

GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


GENOVA DIAGNOSTICS EUROPE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2025







DIRECTORS: Mr O Myerscough-Jenkins
Mr J Ledford
Mr C Thiel



SECRETARY: Mr O Myerscough-Jenkins



REGISTERED OFFICE: 46 - 50 Coombe Road
New Malden
Surrey
KT3 4QF



REGISTERED NUMBER: 04273097 (England and Wales)



SENIOR STATUTORY AUDITOR: Neil Raynsford



AUDITORS: Shaw Gibbs (Audit) Limited
Statutory Auditor
Fleming Court
Leigh Road
Eastleigh
Southampton
Hampshire
SO50 9PD

GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

BALANCE SHEET
30 JUNE 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 - -
Tangible assets 6 5,520 10,371
5,520 10,371

CURRENT ASSETS
Debtors 7 823,401 836,680
Cash at bank 309,673 210,179
1,133,074 1,046,859
CREDITORS
Amounts falling due within one year 8 148,043 124,033
NET CURRENT ASSETS 985,031 922,826
TOTAL ASSETS LESS CURRENT
LIABILITIES

990,551

933,197

PROVISIONS FOR LIABILITIES 585 1,623
NET ASSETS 989,966 931,574

CAPITAL AND RESERVES
Called up share capital 9 1,000 1,000
Retained earnings 988,966 930,574
SHAREHOLDERS' FUNDS 989,966 931,574

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 December 2025 and were signed on its behalf by:





Mr O Myerscough-Jenkins - Director


GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025


1. STATUTORY INFORMATION

Genova Diagnostics Europe Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with group companies where any subsidiary that is a party to the transactions is wholly owned within the group or where transactions have been undertaken under normal market conditions. .

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

In respect of long-term contracts and contracts for on-going services, turnover represents the value of work done in the year, including estimates of amounts not invoiced. Turnover in respect of long-term contracts and contracts for on-going services is recognised by reference to the stage of completion.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - at varying rates on cost
Office equipment - Straight line over 3 to 5 years

All fixed assets are initially recorded at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2025


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Operating lease agreements
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profits on a straight line basis over the period of the lease.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 17 (2024 - 19 ) .

5. INTANGIBLE FIXED ASSETS
Computer
software
£   
COST
At 1 July 2024
and 30 June 2025 286,788
AMORTISATION
At 1 July 2024
and 30 June 2025 286,788
NET BOOK VALUE
At 30 June 2025 -
At 30 June 2024 -

GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2025


6. TANGIBLE FIXED ASSETS
Long Office
leasehold equipment Totals
£    £    £   
COST
At 1 July 2024 52,878 80,010 132,888
Additions - 1,228 1,228
At 30 June 2025 52,878 81,238 134,116
DEPRECIATION
At 1 July 2024 52,878 69,639 122,517
Charge for year - 6,079 6,079
At 30 June 2025 52,878 75,718 128,596
NET BOOK VALUE
At 30 June 2025 - 5,520 5,520
At 30 June 2024 - 10,371 10,371

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Amounts owed by group undertakings 799,028 577,700
Other debtors 24,373 258,980
823,401 836,680

Amounts owed by group undertakings are interest free and repayable on demand.

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 50,416 71,533
Taxation and social security 26,448 -
Other creditors 71,179 52,500
148,043 124,033

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
1,000 Ordinary £1 1,000 1,000

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Neil Raynsford (Senior Statutory Auditor)
for and on behalf of Shaw Gibbs (Audit) Limited

GENOVA DIAGNOSTICS EUROPE LTD (REGISTERED NUMBER: 04273097)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2025


11. OTHER FINANCIAL COMMITMENTS

Total future financial commitments, guarantees and contingencies which are not included in the balance sheet amount to £104,500 (2024: £170,500).

This amount is in relation to operating lease commitments which are payable over the next 2 years.

12. ULTIMATE CONTROLLING PARTY

The company's immediate parent company is Genova Diagnostics Inc., a company incorporated in the United State of America.

The registered address of Genova Diagnostics Inc. is 63 Zillicoa Street, Asheville, North Carolina, 28801, USA.

The company's ultimate parent company and controlling party is GNVA Holdings Inc., a company registered in the United States of America, which is the parent of both the smallest and largest groups for which group accounts are prepared and of which the company is a member.

The registered address of GNVA Holdings Inc. is 63 Zillicoa Street, Asheville, North Carolina, 28801, USA.